Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.

It's the clearest view yet of RFK Jr.'s investments and potential conflicts of interest as he works to become HHS secretary.